Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 3/2009

01-03-2009 | Original Article

Descriptive analysis of clinical factors affecting terminally ill cancer patients

Authors: A. M. Jiménez-Gordo, J. Feliu, B. Martínez, J. de-Castro, N. Rodríguez-Salas, N. Sastre, Y. Vilches, E. Espinosa, J. R. Rodríguez-Aizcorbe, M. González-Barón

Published in: Supportive Care in Cancer | Issue 3/2009

Login to get access

Abstract

Goals of work

To make a descriptive analysis of clinical and laboratories parameters in advanced neoplastic patients.

Materials and methods

We interviewed 406 terminally ill cancer patients to study demographic and neoplastic data, 24 graded symptoms, 21 analytical parameters and scales to evaluate general condition, quality of life and independence in daily activities.

Main results

An average of 9.3 symptoms per patient were detected and median survival was 26.5 days. Most frequent symptoms were asthenia (96.8%), anorexia (94.8%), weight loss (88.1%) and pain (80.5%). Principal laboratory abnormalities were high blood sedimentation rate (96%), high cytolysis and cholestasis enzyme levels (50–77%), anemia (81.5%), low protein (66%) and low albumin levels (67%). Symptom prevalence was different according to age, gender, primary tumour, location of metastasis, laboratory parameters, performance status, quality of life or independence in daily-living activities.

Conclusions

We should know more frequent symptoms affecting terminal cancer patients and any factor contributing to it to provide more comfort in the final phases of life.
Literature
1.
Addington-Hall JM, MacDonald LD, Anderson HR (1990) Can the Spitzer quality of life index help to reduce prognostic uncertainty in terminal care? Br J Cancer 62(4):695–699PubMed
2.
Ahmedazai SH, Walsh D (2000) Palliative medicine and modern cancer care. Semin Oncol 27(1):1–6
3.
Allard P, Dionne A (1995) Factors associated with length of survival among 1,081 terminally ill cancer patients. J Palliat Care 11(3):20–24PubMed
4.
Belloc Calmet J, Porta Serra M, Malats Riera N, Gallen Castillo M, Planas Domingo J (1994) El síntoma inicial atribuible al cáncer en los tumores del tubo digestivo. Un análisis de la concordancia entre el paciente y el médico. Med. Clin 103:401–407
5.
Brescia FJ, Adler D, Gray G, Ryan MA, Cimino J, Mamtani R (1990) Hospitalized advanced cancer patients: a profile. J. Pain Symptom Manage 5:221–227PubMedCrossRef
6.
Bruera E (1990) Symptom control in patients with cancer. J Psychosoc Oncol 8:47–73CrossRef
7.
Burkberg J, Penman D, Holland J (1984) Depression in hospitalized cancer patients. Psychosom Med 46:199–212
8.
Chiu TY, Hu WY, Chen CY (2000) Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer 8:311–313PubMedCrossRef
9.
10.
Curtis EB (1991) Common symptoms in patients with advanced cancer. J Palliat Care 7(2):25–29PubMed
11.
Davidson J, Turnbull C, Strickland R, Miller R, Graves K (1986) The Montgomery–Asberg depression scale: reliability and validity. Acta Psychiatr Scand 73:544–548PubMedCrossRef
12.
Donnelly SM, Walsh TD, Rybicki L (1994) The symptoms of advanced cancer in 1000 patients. J Palliat Care 10(4):57
13.
Dowd S, Davidhizar R (1999) Opening up to the Katz Index. Elder Care 11(1):9–12PubMed
14.
Dunphy KP, Amesbury BDW (1990) A comparison of hospice and home care patients: patterns of referral, patient characteristics and predictors of place of death. Palliat Med 4:105–111CrossRef
15.
Expósito MC, Bruera E (1996) Enfoque terapéutico de la deshidratación en pacientes con cáncer terminal. Med Paliat 3(2):59–66
16.
González Barón M, Andreu Rodríguez M, Ordóñez Gallego A (2001) La astenia en el paciente con cáncer. Rev Oncologica 3:292–299
17.
González Barón M, Jalón JJ y Feliu J (1996) Definición del enfermo terminal y preterminal. In: González Barón M, Ordóñez A, Feliú J, Zamora P, Espinosa E. Tratado de Medicina Paliativa y tratamiento de soporte del enfermo con cáncer. Editorial PANAMERICANA, pp. 1083–1090
18.
Grond S, Zech D, Schug SA, Lynch J, Lehmann A (1991) Validation of world health organization guidelines for cancer pain relief during the last days and hours of life. J Pain Symptom Manage 6(7):411–422PubMedCrossRef
19.
Grond S, Zech D, Diefenbach C, Bischoff A (1994) Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. J Pain Symptom Manage 9(6):372–382PubMedCrossRef
20.
Hockley JM, Dunlop R, Davies RJ (1988) Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control team. Br Med J 296:1715–1717
21.
22.
Kurtz ME, Given B, Kurtz JC, Given CW (1994) The interaction of age, symptoms, and survival status on physical and mental health of patients with cancer and their families. Cancer Sup 74(7):2071–2078CrossRef
23.
Lloyd-Williams M, Dennis M, Taylor F (2004) A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med 18:558–563PubMedCrossRef
24.
Lobo A, Chamorro L, Luque A (2002) Validación de las versiones en español de la Montgomery–Asberg depression rating scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Med Clin (Barc) 118(13):493–499
25.
Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Granazio A, Terzoli E, Luzzani M, De Marinis F, Caraceni A, Labianca R (1997) Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian multicenter study group on palliative care. J Pain Symptom Manage 13(1):1–9PubMedCrossRef
26.
Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Galluci M, Frontini L, Piva L, Amadori D (1995) Prediction of survival of patients terminally ill with cancer. Cancer 75(10):2613–2622PubMedCrossRef
27.
28.
Morasso G, Capelli MM, Viterbori P, Di Leo S, Alberisio A, Constantini M, Fiore M, Saccani D, Zeitler G, Verzolatto N, Tirelli W, Lazzari L, Partinico M, Borzoni G, Savian C, Obertino E, Zotti P, Ivaldi GP, Henriquet F (1999) Psychological and symptom distress in terminal cancer patients with met and unmet needs. J Pain Symptom Manage 17(6):402–409PubMedCrossRef
29.
Morris JN, Suissa S, Sherwood S, Wright SM, Greer D (1986) Last days: a study of the quality of life of terminally ill cancer patients. J Chron Dis 39(1):47–62PubMedCrossRef
30.
Müller MJ, Szegedi A, Wetzel H, Benkert O (2000) Moderate and severe depression gradations for the Montgomery–Asberg depression rating scale. J Affective Disorders 60:137–140CrossRef
31.
Passik SD, Dugan W, McDonald MV, Rosenfeld B, Theobald DE, Edgerton S (1998) Oncologists’ recognition of depression in their patients with cancer. J Clin Oncol 16(4):1594–600PubMed
32.
Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. J Pain Symptom Manage 17(4):231–239PubMedCrossRef
33.
Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30(A):1326–1336CrossRef
34.
Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, Smart-Curley T, Kemeny N, Norton L, Hoskins W (1994) Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res 3(3):183–189PubMedCrossRef
35.
Reich WT (1995) El arte de cuidar a los moribundos. En Morir con dignidad: dilemas éticos al final de la vida. Fundación Ciencias de la Salud
36.
Reuben DB, Vincent M, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148:1586–1591PubMedCrossRef
37.
Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S, Picciafuoco M, Boschetti E, Milella G, Ballatori E, Tonato M, Del Favero A (1991) Intra and interobserver variability in cancer patients’ performance status assessed according to Karnofsky and ECOG scales. Ann Oncol 2(6):437–439PubMed
38.
Salud A, Martínez JM, Arnau N (1996) Estudio descriptivo de pacientes terminales ingresados en una unidad socio-sanitaria ubicada en un hospital de agudos. Med Paliat 3(2):53–58
39.
Sarhill N, Mahmoud F, Christie R, Tahir A (2003) Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hospice Palliat Care 20(6):465–473CrossRef
40.
Schuit KW, Sleijfer DT, Meijler WJ, Otter R, Schakenraad J, Van den Bergh FC, Meyboom-de Jong B (1998) Symptoms and functional status of patients with disseminated cancer visiting outpatient departments. J Pain Symptom Manage 16(5):290–297PubMedCrossRef
41.
Schwartz MK (1992) Enzymes as prognostic markers and therapeutic indicators in patients with cancer. Clin Chim Acta 206:77–82PubMedCrossRef
42.
Shelkey M, Wallace M (1999) Katz index of independence in activities of daily living. J Gerontol Nurs 25(3):8–9PubMed
43.
Snaith RP, Harrop FM, Newby DA, Teale C (1986) Grade scores of the Montgomery–Asberg depression and the clinical anxiety scales. Br J Psychiatry 148:599–601PubMedCrossRef
44.
Spitzer WO, Dobson AJ, Hall A, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 34:585–597PubMedCrossRef
45.
Strömgren AS, Groenvold M, Sorensen A, Andersen L (2001) Symptom recognition in advanced cancer. A comparison of nursing records against patient self-rating. Acta Anesthesiol Scand 45(9):1080–1085CrossRef
46.
Tay WKJ, Shaw RJ, Goh CR (1994) A survey of symptoms in hospice patients in Singapore. Ann Acad Med 23(2):191–196
47.
Vainio A (1991) Prevalence of symptoms in cancer. Palliat Med 1991 5:275–276CrossRef
48.
Vainio A, Auvinen A (1996) Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage 12(1):3–10PubMedCrossRef
49.
Verger E, Conill C, Chicote S, Azpiazu P (1993) Valor del Índice de Karnofsky como indicador del pronóstico de vida en pacientes oncológicos en fase terminal. Med Clin (Barc) 100(2):74
50.
Verger E, Salamero M, Conill C (1992) Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group Scoring Scale and viceversa? Eur J Cancer 28 A(8–9):1328–1330CrossRef
51.
Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME (2000) Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160(6):861–868PubMedCrossRef
52.
Waller A, Hershkowitz M, Adunsky A (1994) The effect of intravenous fluid infusion on blood and urine parameters of hydration and on state of consciousness in terminal cancer patients. Am J Hospice Palliat Care, 22–27 Nov–Dec
53.
54.
Wharton RH (2002) Sleeping with the enemy: treatment of fatigue in individuals with cancer. The Oncologist 7:96–99PubMedCrossRef
55.
Zung WK (1971) A rating instrument for anxiety disorders. Psychosomatics XII:371–379
Metadata
Title
Descriptive analysis of clinical factors affecting terminally ill cancer patients
Authors
A. M. Jiménez-Gordo
J. Feliu
B. Martínez
J. de-Castro
N. Rodríguez-Salas
N. Sastre
Y. Vilches
E. Espinosa
J. R. Rodríguez-Aizcorbe
M. González-Barón
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0460-y

Other articles of this Issue 3/2009

Supportive Care in Cancer 3/2009 Go to the issue

Original Article

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

Original Article

Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence

Short Communication

Clostridium difficile-associated disease in children with solid tumors

Letter to the Editor

Seizure associated with palonosetron

Original Article

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

Original Article

Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits